Results 241 to 250 of about 106,528 (297)

Development and Validation of the Japanese Version of the Hyperhidrosis Quality of Life Index

The Journal of Dermatology, EarlyView.
ABSTRACT Hyperhidrosis decreases an individual's quality of life (QOL). The Hyperhidrosis Quality of Life Index (HidroQoL) measures the impact of hyperhidrosis on QOL and has established reliability and validity. However, a Japanese version does not exist.
Sayaka Ogawa, Jun Tayama, Paul Kamudoni, Sam Salek, Peter Bernick, Masakazu Kobayashi, Seiko Nakamichi, Hiroyuki Murota   +7 more
wiley   +1 more source

Underreporting of sleep variables in psoriasis clinical trials

JEADV Clinical Practice
Grace Xiong, Nicholas Hua, Ron Vender
doaj   +1 more source

Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors? [PDF]

JMIR Dermatol
Lim S, Kooper-Johnson S, Chau CA, Chen C, Yang FC, Cobos G.   +5 more
europepmc   +1 more source

Sex Differences in Response and Persistence to Biologic Therapy in Psoriatic Arthritis: A 52‐Week Analysis With Extended Long‐Term Outcomes

The Journal of Dermatology, EarlyView.
ABSTRACT Psoriatic arthritis (PsA) is a chronic immune‐mediated disease with heterogeneous joint and skin manifestations. Although biologic therapies targeting TNFα, IL‐17, and IL‐23 have transformed PsA management, sex‐specific differences in efficacy and treatment persistence remain underexplored.
Keita Ohyachi, Saori Takamura, Kanade Iino, Souichiro Saito, Mizuki Takeuchi, Tomoo Fukuda   +5 more
wiley   +1 more source

Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing Rosa × damascena Mill. Extract. [PDF]

Pharmaceuticals (Basel)
Gavra DI, Kósa D, Pető Á, Józsa L, Ujhelyi Z, Fehér P, Pallag A, Ghitea TC, Frățilă S, Jurca T, Bácskay I.   +10 more
europepmc   +1 more source

Real‐World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP)

The Journal of Dermatology, EarlyView.
ABSTRACT Generalized pustular psoriasis (GPP) is a heterogeneous, systemic neutrophilic inflammatory disease, characterized by chronic symptoms and recurrent flares, which can be potentially life‐threatening. Spesolimab, an interleukin‐36 receptor antagonist, has been approved to treat GPP flares in many countries including Japan.
Akimichi Morita, Yayoi Tada, Yuichiro Tsunemi, Mayumi Komine, Takuro Kanekura, Shinichi Imafuku, Toshiya Takahashi, Xuemei Ding, Nichiren Pillai, Morihisa Saitoh, Rafael Sani Simoes, Nora Pöntynen, Keiichi Yamanaka   +12 more
wiley   +1 more source

Fabrication and characterization of apremilast-loaded zinc oxide-mesoporous silica nanoparticles for psoriasis treatment. [PDF]

Ther Deliv
Rahangdale M, Solanki S, Patil P, Bhavsar D, Sawant K.   +4 more
europepmc   +1 more source

Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones

The Journal of Dermatology, EarlyView.
ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda, Toshihisa Hamada, Makoto Sugaya   +2 more
wiley   +1 more source

Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice. [PDF]

An Bras Dermatol
Mansilla-Polo M, Sahuquillo-Torralba A, Pujol-Marco C, Bargues-Navarro G, Botella-Estrada R.   +4 more
europepmc   +1 more source

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Meng Pan, Jianguo Sun, Makoto Kawashima, You Chan Kim, Mison Chun, Chia‐Yu Chu, Yi‐Hsin Liang, Mee Chang, Delphine Kerob, Brigitte Dreno   +9 more
wiley   +1 more source